From the epicentre of Italy’s pandemic: Take care and keep steady
The DECISION project – European researchers seek to reduce the number of patients dying from cirrhosis
PRESS RELEASE 21 European institutions join forces to tackle end-stage liver disease and liver failure with a systems medicine approach Despite a vast array of available interventions and medications, more than 1 million people die of chronic liver disease (cirrhosis)…
New study indicates exercise can help prevent liver cancer
Exercise retards development of liver cancer by direct effects independent of weight control in an animal model that closely resembles humans with fatty liver disease, report scientists in the Journal of Hepatology. Oxford, April 14, 2020 – Liver cancer is…
EASL-ESCMID Position Paper: Patients with advanced liver disease and transplant recipients require specific care during COVID-19
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic.…
BioMed Alliance submits Joint Statement to EU leaders, as COVID-19 threatens medical associations
Subsequent to the disruption caused by the COVID-19 pandemic, EASL and 32 other leading European medical associations – together forming the Biomedical Alliance in Europe (BioMed Alliance) – have submitted a joint statement to EU leaders. Together, we are calling…
JHEP Reports indexed in PubMed Central
We are delighted to announce that JHEP Reports has been accepted for indexing in PubMed Central after less than one year of publication, reflecting the high quality of the journal and the articles published. All articles published since its launch…
EASL supports new COVID-Hep registry on patients with COVID-19
EASL encourages healthcare professionals to share the EASL supported COVID-Hep registry among its networks. The registry was launched at the University of Oxford, UK in March 2020, to collect data on patients, with liver disease at any stage or liver…
Review summarises liver injury from human coronavirus infections, including SARS-CoV-2
A review published in Liver International journal summarises the characteristics and mechanism of liver injury caused by three highly pathogenic human coronavirus infections: severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory syndrome coronavirus (MERS‐CoV), and SARS‐CoV‐2 infection (referred to…